| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On November 14, 2003
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| 1998D-1146
|
| Microbial effects of antimicrobial new animal drugs/human sa
|
|
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
|
|
| 2003N-0338
|
| Obesity
|
|
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
|
|
|
| 2003N-0509
|
| Agency Emergency Processing Under OMB Review; Experimental Study of Health Claim Disclaimers on Foods
|
|
|
|
|
| 2003P-0029
|
| Remove metered-dose inhalers (MDI) containing moiety albuter
|
|
|
|
|
| 2003P-0140
|
| Refrain from Approving ANDAs for Topical Mupirocin Ointment
|
|
|
|
|
| 2003P-0270
|
| Prohibit False and Misleading Labeling
|
|
|
|
|
| 2003P-0365
|
| Galderma product, solage containing 2% Mequinol, and 0.01% tretinoin, NDA 20-922 can be formulated as a topical solution with the substitution of Hydroquinone at 4% for the 2% mequinol as an ANDA
|
|
|
|
|
|
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| LET
11487
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 89
|
|
|
|
|
| LET
11488
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 89
|
|
|
|
|
| LET
11489
|
| Great American Health Products
|
| Vol #:
|
| 89
|
|
|
|
|
| LET
11490
|
| Taisho Pharmaceutical Calfornia, Inc.
|
| Vol #:
|
| 89
|
|
|
|
|
| LET
11491
|
| Taisho Pharmaceutical California, Inc.
|
| Vol #:
|
| 89
|
|
|
|
|
| LET
11492
|
| Taisho Pharmaceutical California, Inc.
|
| Vol #:
|
| 89
|
|
|
|
|
| LET
11493
|
| Ashbury Biologicals Inc.
|
| Vol #:
|
| 89
|
|
|
|
|
| LET
11494
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 89
|
|
|
|
|
| LET
11495
|
| PhytoPharmica Natural Medicines
|
| Vol #:
|
| 89
|
|
|
|
|
| LET
11496
|
| Source Naturals
|
| Vol #:
|
| 89
|
|
|
|
|
| LET
11497
|
| Metagenics
|
| Vol #:
|
| 89
|
|
|
|
|
| LET
11498
|
| Natures Remedies Ltd.
|
| Vol #:
|
| 89
|
|
|
|
|
| LET
11499
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 89
|
|
|
|
|
| LET
11500
|
| Enzymatic Therapy Natural Medicines
|
| Vol #:
|
| 89
|
|
|
|
|
| LET
11501
|
| Flora, Inc.
|
| Vol #:
|
| 89
|
|
|
|
|
| LET
11502
|
| Flora, Inc.
|
| Vol #:
|
| 89
|
|
|
|
|
| 1998D-1146
|
| Microbial effects of antimicrobial new animal drugs/human sa
|
|
|
|
|
| C 103
|
| Tanja Pederson
|
| Vol #:
|
| 62
|
|
|
|
|
| C 104
|
| Kenneth John Gilmour
|
| Vol #:
|
| 62
|
|
|
|
|
| LET 3
|
| Tina Wimbush
|
| Vol #:
|
| 62
|
|
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| C 7264
|
| Diana Thather
|
| Vol #:
|
| 303
|
|
| | | | | | | | |
|
|
|
|
| C 7265
|
| Janine L. Motta
|
| Vol #:
|
| 303
|
|
|
|
|
| C 7266
|
| Gisele Chandran
|
| Vol #:
|
| 303
|
|
|
|
|
| C 7267
|
| Pauline M. Wohlleber
|
| Vol #:
|
| 303
|
|
|
|
|
| C 7268
|
| Bob Segar
|
| Vol #:
|
| 303
|
|
|
|
|
| C 7269
|
| Lynda McClellan
|
| Vol #:
|
| 303
|
|
|
|
|
| C 7270
|
| Barbara D. Nelson
|
| Vol #:
|
| 303
|
|
|
|
|
| C 7271
|
| Marlene Brito
|
| Vol #:
|
| 303
|
|
|
|
|
| C 7272
|
| Naomi Bailey
|
| Vol #:
|
| 303
|
|
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
|
|
| C 757
|
| Meredith Terrall
|
| Vol #:
|
| 21
|
|
|
|
|
| 2003N-0338
|
| Obesity
|
|
|
|
|
| C
6
|
| Calorie Control Council
|
| Vol #:
|
| 6
|
|
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
|
|
|
| C 4
|
| Kathy Baucher
|
| Vol #:
|
| 1
|
|
|
|
|
| C 5
|
| Doreen Booth
|
| Vol #:
|
| 1
|
|
|
|
|
| C 6
|
| Mathew Kohut
|
| Vol #:
|
| 1
|
|
|
|
|
| C 7
|
| Debbie Haskett
|
| Vol #:
|
| 1
|
|
|
|
|
| C 8
|
| Jeannine Maffucci
|
| Vol #:
|
| 1
|
|
|
|
|
| C 9
|
| Frann Harrison
|
| Vol #:
|
| 1
|
|
|
|
|
| C 10
|
| Joan Kimpf
|
| Vol #:
|
| 1
|
|
|
|
|
| C 11
|
| Deborah B. Haskett
|
| Vol #:
|
| 1
|
|
|
|
|
| C 12
|
| Conny Johnson
|
| Vol #:
|
| 1
|
|
|
|
|
| C 13
|
| Susan Bechtholt
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0509
|
| Agency Emergency Processing Under OMB Review; Experimental Study of Health Claim Disclaimers on Foods
|
|
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003P-0029
|
| Remove metered-dose inhalers (MDI) containing moiety albuter
|
|
|
|
|
| SUP
3
|
| Glaxo SmithKline
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003P-0140
|
| Refrain from Approving ANDAs for Topical Mupirocin Ointment
|
|
|
|
|
| PDN
1
|
| HFD-1 to Hogan & Hartson, LLP
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003P-0270
|
| Prohibit False and Misleading Labeling
|
|
|
|
|
| C 39
|
| Maryanne Appel
|
| Vol #:
|
| 1
|
|
|
|
|
| C 40
|
| Amy Dillon
|
| Vol #:
|
| 1
|
|
